Seedat Yk
Hypertension in developing nations in sub-Saharan Africa
University of KwaZulu-Natal
rapid development second wave epidemic cardiovascular disease flowing developing countries former socialist republics evident data coronary heart disease cerebrovascular disease increasing rapidly rank 1 5 respectively causes global burden year 2020 spite current low prevalence hypertensive subjects countries total number hypertensive subjects developing world high costanalysis possible antihypertensive drug treatment indicates developing countries cannot afford treatment developed countries control hypertension usa 20 blood pressure 14090 mm hg africa 510 blood pressure control hypertension 14090 mm hg varying responses antihypertensive therapy black hypertensive patients black patients respond well thiazide diuretics calcium channel blockers vasodilators like alphablockers hydralazine reserpine poorly betablockers angiotensinconverting enzyme inhibitors receptor antagonists unless combined diuretic comprehensive cardiovascular disease cvd programme africa necessary social economic cultural factors impair control hypertension developing countries hypertension control ideally suited initial component integrated cvd control programme implemented primary prevention populationbased lifestyle linked programme well costeffective methods detection management synergistically linked existing health care infrastructure needs orientated meet emerging challenge cvd empowering community health education